Mobile Menu
WEBINAR

Precision Oncology ONLINE – 2021 Edition

When: October 7, 2021 Time: 3:00 pm

Imagine a world where nearly every cancer patient was diagnosed early, at a treatable stage, had access to targeted therapies and their prognosis was vastly improved. Understanding the deep heterogeneity within tumours may help us get closer to delivering this vision.

Current precision oncology approaches are already impacting patient care, but they remain underused. Targeted therapies do not exist for all tumour types, diagnostic tests are not yet widely implemented in healthcare and there is a wealth of data to sift through in order to find actionable insights. How can we move closer to fulfilling the vision of precision oncology?

Precision Oncology ONLINE is a 3-part webinar series that will bring together global experts to discuss how we can leverage our current knowledge, expand on it and deliver the very best treatment options to patients.

This webinar series will:

  • Provide you with insights into how your peers are approaching precision oncology clinically.
  • Enable you to discover how advances in diagnostics and biomarker development are shifting paradigms and unlocking the next era of precision oncology.
  • Understand how we can collectively overcome the challenges associated with implementation, with a focus on enabling diagnostics.

Webinar 1: Molecular Characterisation of Cancers for Precision Oncology

Thursday, 7th October at 3pm BST/ 4pm CEST/ 10am EDT

With the ongoing research into the omics of cancer, our understanding is rapidly developing. However, the translation of these findings into the clinic is slow. This webinar will focus on how molecular characterisation of tumours can translate into advances in the clinical management of cancers and bring us closer to the promise of precision oncology.

  • Talk 1: Precision Oncology – Opportunities and Challenges
    • Benedikt Westphalen, Medical Lead Precision Oncology, Munich Comprehensive Cancer Centre
  • Talk 2: Molecular Therapies and Precision Medicine for Cholangiocarcinoma
    • Daniela Sia, Assistant Professor, Mount Sinai Liver Cancer Program
  • Talk 3: Getting the right answers for Precision Oncology with the new SureSelect All Human Exome V8
    • Edward Jan, Sr. Global Product Manager, NGS, Diagnostics and Genomics Group, Agilent Technologies

Webinar 2: Advances in Diagnostics and Biomarker Development

Thursday, 14th October at 3pm BST/ 4pm CEST/ 10am EDT

The development of diagnostic assays and biomarkers that can be used in the clinical setting will transform the way molecular information is gathered and utilised in the patient cancer journey. This webinar will focus on research that advances diagnostics and biomarker development for precision oncology.

  • Talk 1: Cancer Biomarkers: Unlocking the Potential of Precision Oncology for Patients and for Health Systems
    • Mark Lawler, Chair in Translational Cancer Genomics, Queen’s University Belfast
  • Talk 2: Colorectal Cancer – Novel Insights and Opportunities to Overcome Therapy Resistance
    • Andrew Beggs, Professor of Translational Genomics, University of Birmingham
  • Talk 3: When tissue is an issue: urine as a liquid biopsy in oncology screening
    • Stephanie Jordaens, Biomedical Scientist, Novosanis and PhD student, University of Antwerp

Webinar 3: Challenges and Opportunities for Precision Oncology

Thursday, 21st October at 3pm BST/ 4pm CEST/ 10am EDT

This webinar will address the challenges that are associated with implementing precision medicine and evaluate whether we are delivering on the promise of precision oncology, and if not, how can we?

  • Talk 1: How Next-Generation Diagnostics Empower Precision Medicine in Leukemia
    • Torsten Haferlach, CEO, Munich Leukaemia Laboratory
  • Talk 2: Cancer Diagnosis – The Future?
    • Richard Roope, Clinician Advisor, CRUK
  • Talk 3: Harnessing genomics to drive change in personalised medicine –
    • Deborah Lakeland, Cancer Genomics Project manager, Lancashire and South Cumbria Cancer Alliance

Speakers

Benedikt Westphalen Benedikt Westphalen, Medical Lead Precision Oncology, Munich Comprehensive Cancer Centre

Daniela Sia Daniela Sia, Assistant Professor, Mount Sinai Liver Cancer Program

Edward Jan Edward Jan, Sr. Global Product Manager, NGS, Diagnostics and Genomics Group, Agilent Technologies

Mark Lawler Mark Lawler, Chair in Translational Cancer Genomics, Queen’s University Belfast

Andrew Beggs Andrew Beggs, Professor of Translational Genomics, University of Birmingham

Stephanie Jordaens Stephanie Jordaens, Biomedical Scientist, Novosanis

Torsten Haferlach Torsten Haferlach, CEO, Munich Leukaemia Laboratory

Richard Roope Richard Roope, Clinician Advisor, CRUK


More on these topics

Cancer / Cancer Research / Oncology

Share this webinar

Article Search